Literature DB >> 23199551

Profile of microRNAs in the plasma of hypertrophic cardiomyopathy patients compared to healthy controls.

María Palacín, Eliecer Coto, Julián R Reguero, César Morís, Victoria Alvarez.   

Abstract

Entities:  

Keywords:  Hypertrophic cardiomyopathy; MicroRNAs; Sarcomeric mutations

Mesh：

Substances：

Year:  2012        PMID： 23199551     DOI： 10.1016/j.ijcard.2012.11.069

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

Review 1.  A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy.

Authors:  Dimitrios Ntelios; Elisavet Georgiou; Sofia Alexouda; Antigoni Malousi; Georgios Efthimiadis; Georgios Tzimagiorgis
Journal:  Heart Fail Rev       Date:  2021-03-03       Impact factor: 4.214

2.  Circulating miR-499a-5p Is a Potential Biomarker of MYH7-Associated Hypertrophic Cardiomyopathy.

Authors:  Natalia Baulina; Maria Pisklova; Ivan Kiselev; Olga Chumakova; Dmitry Zateyshchikov; Olga Favorova
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

Review 3.  MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far.

Authors:  Catarina Roma-Rodrigues; Luís R Raposo; Alexandra R Fernandes
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.